THE WAY FOR OPTIMIZATION OF DISTANT RADIATION THERAPY IN PROSTATE CANCER

THE WAY FOR OPTIMIZATION OF DISTANT RADIATION THERAPY IN PROSTATE CANCER

Background: The rationale for distant gamma therapy (DGT) in prostate cancer patients is the data of its effectiveness in combination with modern planner devices, as well as lower costs, compared to the use of a linear accelerator.Aim: To access the impact of DGT based on a 3D planning software “Amp...

Full description

Bibliographic Details
Main Author:	A. S. Balkanov
Format:	Article
Language:	Russian
Published:	MONIKI 2016-02-01
Series:	Alʹmanah Kliničeskoj Mediciny
Subjects:	prostate cancer radiation therapy 5-year survival costs of radiation therapy prostate-specific antigen elderly comorbidity
Online Access:	https://www.almclinmed.ru/jour/article/view/77

Similar Items

LONG-TERM RESULTS OF EXTERNAL BEAM RADIATION THERAPY IN MEN WITH NEWLY DIAGNOSED PROSTATE CANCER WITH DIFFERENT RISK OF PROGRESSION
by: P. D. Demeshko, et al.
Published: (2015-09-01)

Comparative effectiveness of surgery versus external beam radiation with/without brachytherapy in high‐risk localized prostate cancer
by: Ming Yin, et al.
Published: (2020-01-01)

Stereotactic body radiation therapy (SBRT) in the treatment of oligometastatic prostate cancer
by: Kamran Ali Ahmed, et al.
Published: (2013-01-01)

Rectal dose sparing and prostate immobilization using a rectal balloon in the treatment of prostate cancer with dose escalation conformal radiation therapy
by: Kanyike, Daniel Mukasa
Published: (2008)

Outcomes following negative prostate biopsy for patients with persistent disease after radiotherapy for prostate cancer
by: Jacob H. Cohen, et al.
Published: (2010-02-01)

Multiparametric magnetic resonance imaging in the diagnosis of local recurrence of prostate cancer in patients after radical prostatectomy
by: G. I. Akhverdiyeva, et al.
Published: (2015-12-01)

Editorial: The Evolving Landscape of Stereotactic Body Radiation Therapy for the Management of Prostate Cancer
by: Seth R. Blacksburg, et al.
Published: (2020-12-01)

TOXICITY OF HYPOFRACTIONATED RADIATION THERAPY FOR LOCALLY ADVANCED PROSTATE CANCER
by: Kushnerova E. V., et al.
Published: (2019-09-01)

INFLUENCE OF RISK FACTORS FOR DISEASE PROGRESSION ON TREATMENT RESULTS IN PATIENTS WITH PROSTATE CANCER
by: R. M. Isargapov, et al.
Published: (2021-06-01)

Reducing rectal injury in men receiving prostate cancer radiation therapy: current perspectives
by: Serrano NA, et al.
Published: (2017-07-01)

Propensity Score Matched Comparison of Intensity Modulated Radiation Therapy vs Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Survival Analysis from the National Cancer Database
by: Anthony Ricco, et al.
Published: (2017-08-01)

Postradiation Osteosarcoma in an Older Prostate Cancer Survivor: Case Study and Literature Review with Emphasis on Geriatric Principles
by: Divya Gumber, et al.
Published: (2013-05-01)

Optimal timing of radiotherapy in high risk prostate cancer: Do missed days matter?
by: Shaakir Hasan, et al.
Published: (2021-01-01)

Radiation-induced erectile dysfunction in patients with prostate cancer: current methods of radiotherapy
by: R. V. Novikov, et al.
Published: (2020-11-01)

Consensus Statement on Proton Therapy for Prostate Cancer
by: Curtis M. Bryant, MD, MPH, et al.
Published: (2021-04-01)

POSSIBILITIES OF MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING IN THE PERSONALIZATION OF SALVAGE RADIATION THERAPY IN PATIENTS WITH PROSTATE CANCER RECURRENCE
by: F. A. Kossov, et al.
Published: (2018-05-01)

Cost–Utility Analysis of Radiation Treatment Modalities for Intermediate-Risk Prostate Cancer
by: Najlaa Alyamani, et al.
Published: (2021-06-01)

Association of time to prostate-specific antigen nadir and logarithm of prostate-specific antigen velocity after progression in metastatic prostate cancer with prior primary androgen deprivation therapy
by: Jeremy YC Teoh, et al.
Published: (2017-01-01)

Intermediate PSA half-life after neoadjuvant hormone therapy predicts reduced risk of castration-resistant prostate cancer development after radical prostatectomy
by: Yong Jin Kang, et al.
Published: (2017-11-01)

BEAM THERAPY AND LONG-TERM HORMONAL THERAPY IN PATIENTS WITH PROSTATE CANCER
by: A. O. Karyakin, et al.
Published: (2014-07-01)

BEAM THERAPY AND LONG-TERM HORMONAL THERAPY IN PATIENTS WITH PROSTATE CANCER
by: A. O. Karyakin, et al.
Published: (2014-07-01)

Preclinical and Clinical Status of PSMA-Targeted Alpha Therapy for Metastatic Castration-Resistant Prostate Cancer
by: Asta Juzeniene, et al.
Published: (2021-02-01)

Risk factors for bone loss with prostate cancer in Korean men not receiving androgen deprivation therapy
by: Sun-Ouck Kim, et al.
Published: (2009-04-01)

Outcomes of patients older than 75 years with non-metastatic prostate cancer
by: Yoshiyasu Amiya, et al.
Published: (2017-04-01)

Comparative cost-effectiveness of stereotactic body radiation therapy versus intensity-modulated and proton radiation therapy for localized prostate cancer.
by: Anju eParthan, et al.
Published: (2012-08-01)

How to choose proper local treatment in men aged ≥75 years with cT2 localized prostate cancer?
by: Kun Jin, et al.
Published: (2019-07-01)

Quality of life worsened the most severely in patients immediately after intensity-modulated radiation therapy for prostate cancer
by: Nakai Y, et al.
Published: (2018-10-01)

Salvage conformal radiotherapy for biochemical recurrent prostate cancer after radical prostatectomy
by: Carlos R. Monti, et al.
Published: (2006-08-01)

Role of dose intensification for salvage radiation therapy after radical prostatectomy
by: Marcus eBeck, et al.
Published: (2016-03-01)

Pattern of failure in prostate cancer previously treated with radical prostatectomy and post-operative radiotherapy: a secondary analysis of two prospective studies using novel molecular imaging techniques
by: Lindsay S. Rowe, et al.
Published: (2021-02-01)

COMBINED RADIATION THERAPY FOR PROSTATE CANCER WITH DOSE ESCALATION BRACHYTHERAPY AND ANDROGEN DEPRIVATION
by: Auchynikau V. A., et al.
Published: (2018-09-01)

Impact of local treatment on overall survival of patients with metastatic prostate cancer: systematic review and meta-analysis
by: Arie Carneiro, et al.

ON-LINE RE-OPTIMIZATION OF PROSTATE IMRT PLAN FOR ADAPTIVE RADIATION THERAPY – A FEASIBILITY STUDY AND IMPLEMENTATION
by: Thongphiew, Danthai
Published: (2008)

Local prostate cancer radiotherapy after prostate-specific antigen progression during primary hormonal therapy
by: Pinkawa Michael, et al.
Published: (2012-12-01)

Lower Urinary Tract Symptoms in Prostate Cancer Patients Treated With Radiation Therapy: Past and Present
by: Whi-An Kwon, et al.
Published: (2021-06-01)

Prostate-specific antigen is a predictor of the efficacy of salvage radiation therapy in patients with recurrent prostate cancer after radical prostatectomy
by: Р. V. Bulychkin, et al.
Published: (2019-07-01)

Prostate-specific antigen velocity in diagnosis and prognosis of prostate cancer - a systematic review
by: Arslaan Javaeed, et al.
Published: (2020-05-01)

Analysis of the Correlationship between Prostate Specific Antigen Related Variables and Risk Factor in Patients with Prostate Carcinoma
by: Daoyuan Wang, et al.
Published: (2015-01-01)

Prostate Cancer – Local Treatment after Radiorecurrence: Surgery - Back to the future?
by: Leonardo O. Reis, et al.

Editorial: Optimizing Local Therapy for High-Risk Prostate Cancer: Evidence and Emerging Options
by: Nicholas G. Zaorsky, et al.
Published: (2020-08-01)

Cannot write session to /tmp/vufind_sessions/sess_2r445vjff5nst6lts0qdsbc1v4